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Results: Cartilage cultured in the presence of blood showed a decrease
of proteoglycan synthesis rate of 70%, an increase of proteoglycan release
of 100%, and a decrease of proteoglycan content of 15% after 16 days of
culture (all p<0.05). This blood-induced damage of the cartilage matrix
was limited by IL-4 in a clear dose-dependent way. Addition of 100 ng/ml
IL-4 during blood-exposure reduced the proteoglycan synthesis rate with
only 45%, and decreased the proteoglycan release with 30% compared
to control (all p<0.05). Moreover, proteoglycan content was normalized.
The combination of IL-4 and IL-10 was clearly more protective against
damage caused by blood. This was especially evident for the proteoglycan
synthesis which was completely normalized. Furthermore, treatment with
a combination of the two cytokines was signiﬁcantly better than the effect
of IL-4 and IL-10 alone (p<0.05).
Conclusions: Besides IL-10, as shown previously, also IL-4 protects against
blood-induced cartilage damage. The combination of these two cytokines
is clearly the most protective. In addition to the direct effects on cartilage,
both cytokines are synergistic in inhibition of inﬂammation. As such,
this justiﬁes further evaluation of the combination of IL-4 and IL-10 in
prevention and treatment of blood-induced joint damage.
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Purpose: Bradykinin (BK, H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH) is a
proinﬂammatory and algogenic peptide: it releases inﬂammatory media-
tors and sensitizes sensory afferents through the activation of B2 receptors
expressed on the membrane of several cell types, including synoviocytes
and chondrocytes. Aim of the current investigation was to investigate if BK
and B2 receptor can participate into mechanisms which are involved into
ostearthritis (OA) degenerative events, and to evaluate the possibility to
prevent them through B2 receptor blockade, using the highly selective and
potent B2 receptor antagonist MEN16132 (m.w. 873.16).
Methods: Human chondrocytes (Lonza, CC-2550) were cultured in
F12/DMEM 1:1 added with CGM Singlequots (Lonza, CC-4409) and Gln
2mM and used up to ﬁfth passage. Experiments were performed with
cells at conﬂuence plated onto 24-well plates. Cells were incubated at
the indicated concentration of BK in F12 medium supplemented with
foetal bovine serum (1%), penicillin (50 μg/ml), streptomycin (50 μg/ml),
amphotericin B (0.75 μg/ml), Gln (2 mM), and captopril (1 μM). At the
end of the experiments, surnatants were collected and stored at -80°C
and used for the dosage of interleukin 6 (IL-6), interleukin 8 (IL8), and
metalloproteinase 3 (MMP3). IL-6, IL-8, and MMP3 contents in the super-
natant were assayed by commercially available enzyme immunoassay kits
(Promokine PK-EL-61606, PK-EL-61806, and Biosource KAC1541). Data are
expressed as mean ± s.e.m. or 95% conﬁdence limits in parentheses of 3 to
5 experiments, each in triplicate.
Results: Time-course experiments (2 - 96 h) indicated that BK (1 μM)
induced a release of IL-6, IL-8, and MMP3 which increased over the time,
stably peaked after 24 h of incubation, and remained constant up to 96
h. The maximal production of IL-6, IL-8 and MMP3 induced by BK (24 h
incubation) was 557±39 pg/ml, 1267±169 pg/ml, and 5.52±0.73 ng/ml,
respectively and was resembling that induced by the pleiotropyc cytokine
TNFα (0.1 ng/ml)(817±350 pg/ml, 1778±198 pg/ml, and 1.96±0.2 ng/ml,
respectively). Concentration-response curves to BK (0.1 nM - 1 μM, 24 h)
indicated EC50 values of 10 nM (5.4-18.6) in inducing an augmented release
of IL-6, 9.7 nM (3.7-32.5) for the release of IL-8, and 9.1 nM (1.1-7.6) for
MMP3 secretion. This effect provoked by BK (100 nM, submaximal concen-
tration) were concentration-dependently prevented by the pretreatment
of HCCK (30 min) with the selective B2 receptor antagonist MEN16132,
and IC50 values were 1.7 nM (1.0-2.8) to inhibit IL-6 production, 2.2 nM
(0.7-7.1) for IL-8, and 0.7 nM (0.3-1.4) for inhibition of MMP3 secretion.
Conclusions: These ﬁndings disclose novel actions of BK that imply its pos-
sible involvement in joint degenerative diseases, and indicate B2 receptor
blockade as a potential therapy in OA pathology.
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Purpose: In animal studies of osteoarthritis (OA), increases in cartilage
thickness have been observed at the early phases, due either to cartilage
hypertrophy or edema. Evidence for cartilage thickening in human OA,
however, remains enigmatic. Cross sectional analyses and one longitudinal
study in human with MRI have indicated that medial osteophytes, in the
absence of medial joint space narrowing (JSN), may be associated with
cartilage thickening in the medial femorotibial compartment in human OA,
particularly in the external aspect of the medial femoral condyle (ecMF).
However, comparisons may have been confounded by differences in age,
BMI and other factors.
To eliminate confounding by between-person differences and to enhance
sensitivity, we performed a within-person between-knee analysis of carti-
lage thickness in knees with unilateral osteophytes and without JSN. The
primary endpoint was the between-knee cartilage thickness differences
in ecMF (in subjects with unilateral medial osteophytes), the secondary
endpoint was thickness differences in the external lateral femur (in those
with unilateral lateral osteophytes), and the exploratory endpoints were
thickness differences in all other femorotibial subregions.
Methods: 83 OA Initiative participants were selected from 4800 cases
(public use data sets 0.E.1 [imaging] and 0.2.2 [clinical]), who displayed
deﬁnite osteophytes and no JSN in one knee and no signs of radiographic
OA in the other knee, according to the site readings. The radiographs
were reviewed by a central reader (F.R.) and 61 participants were in-
cluded. Cartilage thickness was measured in four femorotibial cartilage
plates (medial/lateral, femur/tibia) and in 16 femorotibial subregions, using
sagittal DESSwe MR images and dedicated software (Chondrometrics).
Within-person between-knee differences were calculated with a paired
t-test and general linear models. No adjustment for multiple comparisons
was performed.
Results: Of the 61 participants (age 60.8±9.6 yrs; 29m/32f; BMI 27.8±4.7)
48% displayed medial, 36% lateral, and 16% bicompartimental (mostly tibial)
osteophytes. Knees with osteophytes had thicker cartilage than contralat-
eral knees in the external medial (ecMF:+5.5%,p=0.02) and external lateral
femur (ecLF:+4.1%,p=0.01), but in no other subregions. Knees with only
medial osteophytes displayed greater thickening in ecMF (+7.8%) than ecLF
(-0.1%), those with only lateral osteophytes greater thickening in ecLF
(+5.0%) than in ecMF (+1.7%), and those with bicompartimental osteophytes
similar thickening in both subregions (+17%/+15%, respectively). There was
no signiﬁcant effect of age, sex, or BMI on between-knee differences.
Conclusions: Knees with early radiographic OA (deﬁnite osteophytes, no
JSN) displayed thicker cartilage than the contralateral knees without radio-
graphic OA. The differences were speciﬁc to external medial femoral and
external lateral femoral subregions and appeared to be locally mediated by
(tibial) osteophytes in the same compartment.
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Purpose: Oxidative phosphorylation takes place at the mitochondrial res-
piratory chain and is the major source for the production of ATP. A
by-product of this respiration are reactive oxygen species (ROS). ROS are
involved in signalling processes but when at high levels contribute to
oxidative damage. The major ROS include superoxide (O2•–) and hydrogen
peroxide (H2O2). The mRNA and protein levels of the major inhibitor of
superoxides in the mitochondria, superoxide dismutase 2 (SOD2), have
been shown to be downregulated in osteoarthritic compared to healthy
joint cartilage.
This study characterises the effects of reduced levels of SOD2 on chondro-
